SIGRID Partners With Pure Pharmacy as its Exclusive Miami Retailer
The Natural Silica-Based Supplement Effective at Controlling Blood Sugar and Weight is Now available at Pure Pharmacy MIAMI, Jan. 2, 2024 /PRNewswire/ — SIGRID’s Glucose Stabiliser is now exclusively sold in Miami at independent pharmacy, Pure Pharmacy. With Pure Pharmacy’s commit
enCore Energy Commences Trading on Nasdaq Capital Market
NASDAQ:EUTSXV:EUwww.encoreuranium.com DALLAS, Jan. 2, 2024 /PRNewswire/ – enCore Energy Corp. (“enCore” or the “Company”) (NASDAQ: EU) (TSXV: EU), a uranium producer in the United States, commences trading on the Nasdaq Capital Market (“Nasdaq”) today. The
Labcorp to Speak at the 42nd Annual J.P. Morgan Healthcare Conference
BURLINGTON, N.C., Jan. 2, 2024 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a fireside chat at the 42nd Annual J.P. Morgan Healthcare Conference on Tuesd
Harvest Partners Announces Promotions
NEW YORK, Jan. 2, 2024 /PRNewswire/ — Harvest Partners, LP (“Harvest” or “the Firm”) is pleased to announce the promotions of Shane McHugh to Principal and Claire Simon to Vice President. “We congratulate Shane and Claire on these well-deserved advancements,”
Agriculture & Natural Solutions Acquisition Corporation Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing January 2, 2024
NEW YORK, Jan. 2, 2024 /PRNewswire/ — Agriculture & Natural Solutions Acquisition Corporation (NASDAQ: ANSCU) (the “Company”) announced that, commencing January 2, 2024, holders of the units sold in the Company’s initial public offering may elect to separately trade the C
South Rampart Pharma Successfully Completes Phase 1 Study and Expands Phase 2 Plans to Include Neuropathic and Acute Pain Trials
Phase 1 data demonstrate that SRP-001 exhibits an exceptionally strong safety and robust pharmacokinetic profile and is well-toleratedWell-designed Phase 2 trials set to show statistical significance compared to placebo and positive control NEW ORLEANS, Jan. 2, 2024 /PRNewswire/ — South Rampar
Emissary Launches Innovative Sales Intelligence Platform, Emissary Knowledge, Giving Sales Leaders an Information Advantage.
NEW YORK, Jan. 2, 2024 /PRNewswire/ — In a significant evolution of the sales intelligence marketplace, Emissary today unveiled Emissary Knowledge. Unlike conventional intelligence tools which scrape publicly available information from the Web, Emissary’s firsthand insights are sourced
JW Therapeutics Announces Exclusive Collaboration with 2seventy bio for Autoimmune Disease CAR-T Therapy
SHANGHAI, Jan. 2, 2024 /PRNewswire/ — JW Therapeutics (HKEx: 2126), an independent innovative biotechnology company focused on developing, manufacturing and commercializing cell immunotherapy products, is pleased to announce an exclusive collaboration with 2seventy bio (NASDAQ: TSVT), for the
DISH Network Convertible Notes Become Convertible Into Shares of EchoStar Corporation
ENGLEWOOD, Colo., Jan. 2, 2024 /PRNewswire/ — DISH Network Corporation (“DISH”) today announced that, in connection with the closing of the merger between DISH and EchoStar Corporation (“EchoStar”) on December 31, 2023, as a result of which DISH survived the merger as
